VP Mike Pence Visits Miami as UM tests COVID Vaccine

first_img“The COVID-19 pandemic is having a tremendous impact in South Florida and across the world,” said Dr. Susanne Doblecki-Lewis, an infectious disease expert at the University of Miami who will lead the initiative. “We are testing vaccines with the goal of finding a safe and effective way to halt the spread of the virus.” The clinical trials will test a vaccine developed by National Institutes of Health scientists and their collaborators at the biotechnology company ModernaTX Inc.Prospective volunteers for the study will need to be at least 18 years old. A news release said the school plans to use community outreach and mobile operations to recruit from a wide variety of demographics. To register to volunteer, you can sign up by clicking here“We are committed to engaging people who represent the range of residents impacted by COVID-19 in South Florida by gender, age, race, and ethnicity, as well as those who are particularly at-risk because of medical conditions,” said Doblecki-Lewis. “This is how we will help ensure that any vaccine that is developed will be relevant for those who could benefit most from it.”Participants are paid for their time and inconvenience during what is scheduled to be a three-month study. Vice President Mike Pence visits the University of Miami today to discuss a possible coronavirus breakthrough.Mike Pence will visit the University of Miami, where clinical trials are getting under way on a vaccine.About a thousand people will be part of a clinical trial involving a vaccine developed by Moderna. The university’s Miller School of Medicine is taking part in the “Phase 3” trial of the vaccine.Pence will take part in a roundtable discussion with school leaders and members of the Miller School of Medicine along with researchers on what could help in the ongoing battle: https://t.co/hpMa8fMdDq— NBC 6 South Florida (@nbc6) July 27, 2020last_img


Leave a Reply

Your email address will not be published. Required fields are marked *